Skip to main content
. Author manuscript; available in PMC: 2009 Jul 7.
Published in final edited form as: Neuropeptides. 2008 Apr 14;42(3):245–253. doi: 10.1016/j.npep.2008.03.001

Table 2. Effects of LY225.910 (0.5 mg/Kg) on general activity in the OF sequence.

Injections were given 30 min before the first test session on day 1 (D0 post-drug). Drug-free test sessions were conducted on day 3 (D2 post-drug), 5 (D4 post-drug), and 7 (D6 post-drug).Data are in mean ± S.E.M, N = 8.

Line crossings Day 1 Day 3 Day 5 Day 7
Vehicle-HR 54 ± 11 67 ± 11 53 ± 9 66 ± 10
LY225.910-HR 65 ± 8 75 ± 10 64 ± 12 69 ± 13
Vehicle-LR 35 ± 9 49 ± 11 31 ± 9 46 ± 11
LY225.910-LR 36 ± 9 41 ± 10 44 ± 11 54 ± 14
Centre entries
Vehicle-HR 4 ± 2 6 ± 1 4 ± 1 7 ± 2
LY225.910-HR 4 ± 1 7 ± 2 4 ± 1 8 ± 2
Vehicle-LR 1 ± 1 4 ± 1 3 ± 1 5 ± 2
LY225.910-LR 2 ± 1 3 ± 1 2 ± 1 5 ± 2